ITMI20051231A1 - Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale - Google Patents

Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale

Info

Publication number
ITMI20051231A1
ITMI20051231A1 IT001231A ITMI20051231A ITMI20051231A1 IT MI20051231 A1 ITMI20051231 A1 IT MI20051231A1 IT 001231 A IT001231 A IT 001231A IT MI20051231 A ITMI20051231 A IT MI20051231A IT MI20051231 A1 ITMI20051231 A1 IT MI20051231A1
Authority
IT
Italy
Prior art keywords
folinated
affections
oral
calcium
cable
Prior art date
Application number
IT001231A
Other languages
English (en)
Inventor
Rosa Gobbi
Original Assignee
Pharmaproducts Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaproducts Uk Ltd filed Critical Pharmaproducts Uk Ltd
Priority to IT001231A priority Critical patent/ITMI20051231A1/it
Priority to EP06779775A priority patent/EP1906979A1/en
Priority to PCT/IB2006/001746 priority patent/WO2007000648A1/en
Publication of ITMI20051231A1 publication Critical patent/ITMI20051231A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT001231A 2005-06-29 2005-06-29 Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale ITMI20051231A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT001231A ITMI20051231A1 (it) 2005-06-29 2005-06-29 Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale
EP06779775A EP1906979A1 (en) 2005-06-29 2006-06-27 Pharmaceutical formulations containing colostrum and calcium folinate for te treatment of disorders of the oral cavity
PCT/IB2006/001746 WO2007000648A1 (en) 2005-06-29 2006-06-27 Pharmaceutical formulations containing colostrum and calcium folinate for te treatment of disorders of the oral cavity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001231A ITMI20051231A1 (it) 2005-06-29 2005-06-29 Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale

Publications (1)

Publication Number Publication Date
ITMI20051231A1 true ITMI20051231A1 (it) 2006-12-30

Family

ID=37196323

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001231A ITMI20051231A1 (it) 2005-06-29 2005-06-29 Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale

Country Status (3)

Country Link
EP (1) EP1906979A1 (it)
IT (1) ITMI20051231A1 (it)
WO (1) WO2007000648A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20080174A1 (it) * 2008-02-05 2009-08-06 You Biomedical Research Srl Composizioni topiche a base di colostro, folati e miele rosato per il trattamento delle affezioni della cavita' orale
WO2013098331A1 (en) 2011-12-30 2013-07-04 Bionest Ltd. Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, and chemotactic factors
DK2797609T3 (en) 2011-12-30 2017-01-09 Innomed S A COMBINING growth factors, cytokines, anti-bacterial / ANTIVIRALS FACTORS STEM CELL-STIMULATING FACTORS, complement C3A / C4A, immunoglobulins, and chemotactic factors
ITMI20112446A1 (it) * 2011-12-30 2013-07-01 Bionest Ltd Composizione per la terapia delle lesioni della mucosa orale
US10272083B2 (en) 2014-01-21 2019-04-30 Acerta Pharma B.V. Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
PL3954690T3 (pl) 2015-07-02 2023-08-14 Acerta Pharma B.V. Postacie stałe i formulacje (s)-4-(8-amino-3-(1-(but-2-ynoilo)pirolidyn-2-ylo)imidazo[1,5-a]-pirazyn-1-ylo)-n-(pirydyn-2-ylo)benzamidu
US20190076497A1 (en) * 2017-09-11 2019-03-14 Kenneth Davin Fine Oral and intestinal health products
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500711A (en) * 1977-03-21 1985-02-19 Burroughs Wellcome Co. Synthesis of leucovorin
FR2627386A1 (fr) * 1988-02-22 1989-08-25 Serge Liotet Composition a usage externe destinee a l'administration oculaire
DE69309712T2 (de) * 1993-01-26 1997-10-23 Horse Vitality Ltd Pharmazeutische und dermokosmetische mittel enthaltend pferdecolostrum
IT1291340B1 (it) * 1997-05-09 1999-01-07 Vander Way Limited Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale

Also Published As

Publication number Publication date
EP1906979A1 (en) 2008-04-09
WO2007000648A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
CY2013022I1 (el) Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
ITMI20020756A0 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
HUE041944T2 (hu) Alacsony dózisú imiquimod készítmények és rövid adagolási módszer aktinikus keratózis kezelésére
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
IL217540A (en) Oral composition for use in oral disinfection or in treating an oral disease
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
CY2014026I2 (el) Συνθεσεις και χρησεις για θεραπεια σκληρυνσης κατα πλακας
ZA200610055B (en) Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
IL189622A (en) Pharmaceuticals for the treatment of facial and ear disorders
EP2046315A4 (en) THERAPEUTIC AGENTS FOR THE TREATMENT OF LYMPHOID MALIGNANCIES
HUS1500058I1 (hu) Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
ZA200908928B (en) Formulations for the oral administration of therapeutic agents and related methods
EP2114418A4 (en) ORAL DOSAGE FORM WITH STABILIZED PICOPLATIN
ITMI20051231A1 (it) Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
EP2349285A4 (en) METHOD FOR TREATING OR PREVENTING PAIN WITH THE HELP OF SPICAMYCIN DERIVATIVES
IT1390968B1 (it) Frazione glicolipidica di cianobatterio per il trattamento delle affezioni del cavo orale
SI2344166T1 (sl) Farmacevtska sestava za zdravljenje gastrointestinalnih iritacij
HU0500145D0 (en) Composition for the treatment of oral diseases
ITMI20040989A1 (it) Uso del sulglicotide per iul trattamento delle mucositi